What is non-celiac gluten sensitivity and how is it different from celiac disease?
Non-celiac gluten sensitivity (NCGS) is a condition where people develop symptoms after eating gluten, but they do not have celiac disease or a wheat allergy. The key difference is that celiac disease is an autoimmune disorder that damages the lining of the small intestine (enteropathy), while NCGS does not cause this damage. A 2024 review explains that in celiac disease, gluten triggers an immune reaction leading to malabsorption and symptoms, whereas in NCGS the mechanism is unknown and gluten does not cause enteropathy or malabsorption [8]. This means that while a strict gluten-free diet is essential for celiac disease to prevent intestinal damage, a less strict gluten-restricted diet may be enough to control symptoms in NCGS [8].
Research has identified distinct biological differences between the two conditions. A 2026 study measuring inflammatory markers found that celiac disease patients had significantly higher levels of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α) compared to NCGS patients and healthy controls (p < 0.001), suggesting that NCGS involves a different, less severe inflammatory response [2]. Another 2024 study using serum metabolomics (analysis of blood chemicals) was able to distinguish celiac disease from NCGS with 90% accuracy, pointing to differences in gut microbiota and metabolism [7]. These findings confirm that NCGS is not just a milder form of celiac disease but a biologically separate condition.
How common is NCGS and what symptoms does it cause?
NCGS is surprisingly common, especially among people with irritable bowel syndrome (IBS). A large 2026 survey of over 5,000 young Italian adults found that 29.1% of those with IBS also met criteria for NCGS, compared to only 8.6% of those without IBS [1]. A separate 2022 study in Southern Italy found a prevalence of self-reported NCGS of 8.4% in the general population [3]. These numbers show that NCGS affects a significant minority of people, and it frequently overlaps with IBS.
The symptoms of NCGS are similar to celiac disease and include both intestinal and extraintestinal issues. The Italian survey found that people with NCGS more often reported fatigue, foggy mind, lack of well-being, and neuropsychiatric disorders compared to those with IBS alone [1]. Another study noted that symptoms typically include bloating, acid reflux, headache, and anxious-depressive disorders, with rapid onset after meals (39% within 6 hours) and lasting at least 6 months in 74% of cases [3]. A 2021 pilot study also found a strong link between NCGS and migraine headaches, with 9 out of 10 NCGS patients having reduced activity of the enzyme diamine oxidase (DAO), which breaks down histamine — suggesting that histamine intolerance may play a role in NCGS symptoms [4].
How is NCGS diagnosed and why is it tricky?
Currently, there is no single blood test or biopsy that can diagnose NCGS. Diagnosis relies on clinical criteria: symptoms that improve on a gluten-free diet and return when gluten is reintroduced, after ruling out celiac disease and wheat allergy. A 2025 review states that 'no specific biomarker of NCGS has been detected' and that diagnosis still depends on a gluten challenge, though a strong nocebo effect (people feeling worse because they expect to) limits its reliability [6]. The same review notes that serum IgG class antigliadin antibodies and certain intestinal biopsy features have been explored but are not definitive [6].
Because the symptoms overlap so much with IBS and celiac disease, proper testing is essential. A 2022 letter to the editor strongly recommends that anyone with gluten-related symptoms be tested for celiac disease before considering NCGS, noting that in their Italian study, 1.5% of people who thought they had NCGS actually had celiac disease [3]. The good news is that research is progressing: studies have found that NCGS patients have distinct changes in their gut microbiome's ability to digest gluten (altered peptidase enzymes) [5], and that their serum metabolite profiles differ from celiac disease [7]. These discoveries may lead to a reliable diagnostic test in the future.
About These Sources
This answer is built on 8 peer-reviewed studies — published from 2021 to 2026, 5 from 2024 or later, 4 in Q1 journals — selected as the most relevant from 15 studies that passed quality screening, drawn from 42 papers retrieved from a database of over 500 million.
Sources used in this answer
Self-reported Nonceliac Gluten Sensitivity in Patients With Irritable Bowel Syndrome
In a cross-sectional survey of 5,108 young Italian adults, 29.1% of those with irritable bowel syndrome also met criteria for non-celiac gluten sensitivity, compared to 8.6% of those without IBS.
Assessment of IL-8 and TNF-α Status as Inflammatory Mediators in Celiac and Non-Celiac Gluten-Sensitive Disease
In a case-control study of 80 celiac patients, 20 NCGS patients, and 80 controls, celiac patients had significantly higher IL-8 and TNF-α levels than NCGS patients and controls (p < 0.001), suggesting distinct inflammatory profiles.
Non-celiac Gluten Sensitivity or Celiac Disease, This Is Still the Question
In a survey of 2,301 people in Southern Italy, the prevalence of self-reported NCGS was 8.4%, with symptoms similar to IBS; 1.5% of those with gluten-related symptoms actually had celiac disease.
Associations between migraine, celiac disease, non-celiac gluten sensitivity and activity of diamine oxidase.
In a pilot study of 44 migraine patients, 10 met criteria for NCGS, and 9 of those had reduced serum diamine oxidase activity, suggesting a link between NCGS, histamine intolerance, and migraine.
Microbial-derived peptidases are altered in celiac disease, non-celiac gluten sensitivity, and functional dyspepsia: a systematic review and re-analysis of the duodenal microbiome
A systematic review and re-analysis of duodenal microbiome data found that microbial peptidases (enzymes that digest gluten) are altered in celiac disease, NCGS, and functional dyspepsia, suggesting impaired gluten digestion by the microbiome.
An overview of progress in establishing a diagnostic tool for non-celiac gluten sensitivity
A review concluded that no specific biomarker for NCGS has been identified; diagnosis still relies on clinical criteria and gluten challenge, which is limited by a strong nocebo effect.
Serum metabolomics and lipoproteomics discriminate celiac disease and non-celiac gluten sensitivity patients
Using serum metabolomics and lipoproteomics, researchers could distinguish celiac disease from NCGS with 90% accuracy, suggesting differences in gut microbiota and metabolism between the two conditions.
Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity
A review explains that celiac disease requires a strict gluten-free diet to prevent enteropathy, while NCGS may only need a gluten-restricted diet; both carry risks of nutritional deficiencies.